Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Dec-13 2:58 PM View:  | April Gary M President, HCP Division | Hi Tech Pharmacal Co. Inc. (HITK) | 13-Dec-13 | Market Option Sale | 6,873 | $43.06 | $295,951.00 | (100%) 6.87K to 0 | (< 1%) |
| 17-Dec-13 2:58 PM View: | April Gary M President, HCP Division | Hi Tech Pharmacal Co. Inc. (HITK) | 13-Dec-13 | Option Exercise | 6,873 | $25.92 | $178,177.00 | 100% 0 to 6.87K | |
| 10-Oct-13 5:58 PM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 10-Oct-13 | Market Option Sale | 11,250 | $43.13 | $485,212.00 | (1%) 835.32K to 824.07K | (< 1%) |
| 10-Oct-13 5:58 PM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 10-Oct-13 | Option Exercise | 11,250 | $10.93 | $122,962.00 | 1% 824.07K to 835.32K | |
| 10-Oct-13 4:52 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 09-Oct-13 | Payment of Exercise | 26,091 | $43.09 | $1,124,260.00 | (2%) 1.59M to 1.56M | (< 1%) |
| 10-Oct-13 4:52 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 09-Oct-13 | Option Exercise | 75,000 | $14.99 | $1,124,250.00 | 5% 1.52M to 1.59M | |
| 10-Oct-13 4:52 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 08-Oct-13 | Market Option Sale | 23,000 | $43.09 | $991,070.00 | (1%) 1.54M to 1.52M | (< 1%) |
| 08-Oct-13 5:18 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 04-Oct-13 | Market Option Sale | 1,500 | $43.10 | $64,650.00 | (100%) 1.5K to 0 | (< 1%) |
| 08-Oct-13 5:18 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 04-Oct-13 | Option Exercise | 1,500 | $24.95 | $37,425.00 | 100% 0 to 1.5K | |
| 04-Oct-13 2:00 PM View: | Peters William J EVP & Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 03-Oct-13 | Option Exercise | 21,250 | $15.03 | $319,488.00 | 100% 0 to 21.25K | |
| 04-Oct-13 2:00 PM View: | Peters William J EVP & Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 03-Oct-13 | Market Option Sale | 21,250 | $43.11 | $916,088.00 | (100%) 21.25K to 0 | (< 1%) |
| 04-Oct-13 2:01 PM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 02-Oct-13 | Option Exercise | 11,250 | $13.50 | $151,875.00 | 1% 824.07K to 835.32K | |
| 04-Oct-13 2:02 PM View: | Simpson Bruce W Director | Hi Tech Pharmacal Co. Inc. (HITK) | 02-Oct-13 | Market Option Sale | 10,100 | $43.14 | $435,714.00 | (100%) 10.1K to 0 | (< 1%) |
| 04-Oct-13 2:01 PM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 02-Oct-13 | Market Option Sale | 11,250 | $43.13 | $485,212.00 | (1%) 835.32K to 824.07K | (< 1%) |
| 04-Oct-13 2:02 PM View: | Simpson Bruce W Director | Hi Tech Pharmacal Co. Inc. (HITK) | 01-Oct-13 | Option Exercise | 25,468 | $22.32 | $568,488.00 | 100% 0 to 25.47K | |
| 04-Oct-13 2:02 PM View: | Simpson Bruce W Director | Hi Tech Pharmacal Co. Inc. (HITK) | 01-Oct-13 | Market Option Sale | 15,368 | $43.15 | $663,129.00 | (60%) 25.47K to 10.1K | (< 1%) |
| 01-Oct-13 12:41 PM View: | April Gary M President, HCP Division | Hi Tech Pharmacal Co. Inc. (HITK) | 30-Sep-13 | Market Option Sale | 3,125 | $43.08 | $134,625.00 | (100%) 3.13K to 0 | (< 1%) |
| 01-Oct-13 12:42 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 30-Sep-13 | Option Exercise | 3,111 | $13.50 | $41,998.50 | 100% 0 to 3.11K | |
| 01-Oct-13 12:41 PM View: | April Gary M President, HCP Division | Hi Tech Pharmacal Co. Inc. (HITK) | 30-Sep-13 | Option Exercise | 3,125 | $32.59 | $101,844.00 | 100% 0 to 3.13K | |
| 01-Oct-13 12:42 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 30-Sep-13 | Disposition (other) | 3,111 | -- | -- | (100%) 3.11K to 0 | |
| 01-Oct-13 12:42 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 27-Sep-13 | Option Exercise | 7,308 | $18.20 | $133,008.00 | 100% 0 to 7.31K | |
| 01-Oct-13 12:42 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 27-Sep-13 | Disposition (other) | 4,308 | -- | -- | (59%) 7.31K to 3.0K | |
| 01-Oct-13 12:42 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 27-Sep-13 | Market Option Sale | 3,000 | $43.10 | $129,300.00 | (100%) 3.0K to 0 | (< 1%) |
| 04-Oct-13 6:04 PM View: | Hirshaut Yashar Director | Hi Tech Pharmacal Co. Inc. (HITK) | 17-Sep-13 | Option Exercise | 11,250 | $13.50 | $151,875.00 | 25% 45.5K to 56.75K | |
| 05-Feb-13 5:32 PM View: | Peters William J VP and Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 05-Feb-13 | Market Option Sale (Planned) | 36 | $38.00 | $1,368.00 | (100%) 36 to 0 | (14%) |
| 05-Feb-13 5:32 PM View: | Peters William J VP and Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 05-Feb-13 | Option Exercise | 36 | $10.68 | $384.48 | 100% 0 to 36 | |
| 05-Feb-13 5:32 PM View: | Peters William J VP and Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 01-Feb-13 | Option Exercise | 4,603 | $10.68 | $49,160.00 | 100% 0 to 4.6K | |
| 05-Feb-13 5:32 PM View: | Peters William J VP and Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 01-Feb-13 | Market Option Sale (Planned) | 4,603 | $38.00 | $174,914.00 | (100%) 4.6K to 0 | (14%) |
| 28-Jan-13 5:31 PM View: | Peters William J VP and Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 24-Jan-13 | Option Exercise | 7,861 | $10.68 | $83,955.50 | 100% 0 to 7.86K | |
| 28-Jan-13 5:31 PM View: | Peters William J VP and Chief Financial Officer | Hi Tech Pharmacal Co. Inc. (HITK) | 24-Jan-13 | Market Option Sale (Planned) | 7,861 | $38.00 | $298,718.00 | (100%) 7.86K to 0 | (14%) |
| 11-Jan-13 3:09 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 09-Jan-13 | Option Exercise | 112,500 | $11.56 | $1,300,500.00 | 8% 1.46M to 1.57M | |
| 11-Jan-13 3:09 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 09-Jan-13 | Payment of Exercise | 35,092 | $37.06 | $1,300,510.00 | (2%) 1.57M to 1.54M | (17%) |
| 11-Jan-13 3:09 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 26-Dec-12 | Gift | 1,050 | -- | -- | < 1% 1.46M to 1.46M | |
| 13-Jun-13 9:39 AM View: | Seltzer Reuben Vice Chairman-Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 26-Dec-12 | Gift | 350 | -- | -- | < 1% 821.27K to 821.62K | |
| 13-Jun-13 9:39 AM View: | Seltzer Reuben Vice Chairman-Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 26-Dec-12 | Gift | 2,450 | -- | -- | < 1% 821.62K to 824.07K | |
| 11-Jan-13 3:09 PM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 26-Dec-12 | Gift | 350 | -- | -- | < 1% 1.46M to 1.46M | |
| 12-Dec-12 5:07 PM View: | April Gary M President, HCP Division | Hi Tech Pharmacal Co. Inc. (HITK) | 10-Dec-12 | Market Option Sale | 5,626 | $35.44 | $199,385.00 | (100%) 5.63K to 0 | (28%) |
| 12-Dec-12 5:07 PM View: | April Gary M President, HCP Division | Hi Tech Pharmacal Co. Inc. (HITK) | 10-Dec-12 | Option Exercise | 5,626 | $15.89 | $89,403.50 | 100% 0 to 5.63K | |
| 15-Nov-12 12:55 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 14-Nov-12 | Disposition (other) | 2,832 | -- | -- | (100%) 2.83K to 0 | |
| 15-Nov-12 12:55 PM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 14-Nov-12 | Option Exercise | 2,832 | $8.31 | $23,533.90 | 100% 0 to 2.83K | |
| 08-Nov-12 1:25 PM View: | Hirshaut Yashar Director | Hi Tech Pharmacal Co. Inc. (HITK) | 05-Nov-12 | Option Exercise | 11,250 | $8.31 | $93,487.50 | 33% 34.25K to 45.5K | |
| 18-Oct-12 9:12 AM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 16-Oct-12 | Market Sale | 6,800 | $32.56 | $221,408.00 | (< 1%) 828.07K to 821.27K | (39%) |
| 17-Oct-12 10:23 AM View: | van Hulst Jack Director | Hi Tech Pharmacal Co. Inc. (HITK) | 16-Oct-12 | Market Option Sale | 3,000 | $32.75 | $98,250.00 | (100%) 3.0K to 0 | (38%) |
| 18-Oct-12 9:37 AM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 16-Oct-12 | Option Exercise | 421 | $19.59 | $8,247.39 | 100% 0 to 0.42K | |
| 17-Oct-12 10:23 AM View: | van Hulst Jack Director | Hi Tech Pharmacal Co. Inc. (HITK) | 16-Oct-12 | Option Exercise | 3,000 | $5.83 | $17,490.00 | 100% 0 to 3.0K | |
| 18-Oct-12 9:37 AM View: | Goldwyn Martin M Director | Hi Tech Pharmacal Co. Inc. (HITK) | 16-Oct-12 | Disposition (other) | 421 | -- | -- | (100%) 0.42K to 0 | |
| 17-Oct-12 10:23 AM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 16-Oct-12 | Market Sale | 29,441 | $32.60 | $959,777.00 | (2%) 1.49M to 1.46M | (39%) |
| 17-Oct-12 10:23 AM View: | Seltzer David S CEO, President, Sec'y, Treas. Director 10% Owner | Hi Tech Pharmacal Co. Inc. (HITK) | 15-Oct-12 | Market Sale | 20,559 | $32.97 | $677,830.00 | (1%) 1.51M to 1.49M | (37%) |
| 18-Oct-12 9:12 AM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 15-Oct-12 | Market Sale | 3,200 | $33.47 | $107,104.00 | (< 1%) 831.0K to 827.8K | (35%) |
| 15-Oct-12 4:29 PM View: | Seltzer Reuben Vice Chairman, Business Dev't Director | Hi Tech Pharmacal Co. Inc. (HITK) | 12-Oct-12 | Market Option Sale | 1,250 | $33.01 | $41,262.50 | (< 1%) 842.52K to 841.27K | (37%) |
